SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after achieving its first-ever quarterly profit amidst strong delivery growth, sparking fervent community discussion about a potential short squeeze and its long-term undervaluation given its unique battery swap technology and new chip innovations.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is seeing extreme volatility as crude oil prices first surged on escalating Middle East tensions and potential Strait of Hormuz disruptions, then sharply reversed following Donald Trump's comments suggesting the Iran conflict is "very complete" and supply concerns are easing. The community is actively debating whether this represents a "rug pull" and a market top, or if it's a temporary dip before another rebound amid lingering geopolitical risks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending following news of a $30M acceleration program for its Tanbreez Heavy Rare Earth project, fueling community debate about potential resource expansion and the upcoming Bankable Feasibility Study. Bulls foresee a significant re-rating in the strategically vital rare earth sector, while others eye the stock cautiously given past volatility and skepticism regarding prior economic assessments.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending due to widespread anticipation of major commercial contracts and an upcoming NASDAQ uplisting, following recent global regulatory approvals for its high-purity graphene technology. The community is actively discussing its potential to revolutionize industries from defense to semiconductors, while debating its current valuation against long-term growth prospects.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is trending after recent analyst upgrades and positive sentiment from its Barclays conference, where CEO Chuck Divita highlighted AI integration and a clear strategy for BetterHelp's turnaround with insurance and international growth. The community is actively discussing the company's perceived undervaluation and potential for a short squeeze as management focuses on execution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending after reporting strong financial results that exceeded analyst expectations, signaling a shift to profitability driven by accelerating sales of its rare disease drug, MIPLYFFA. The community is actively discussing the company's undervalued status and speculating on upcoming catalysts, including potential European regulatory approval and a strategic acquisition.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is a top trending stock ahead of its crucial earnings report, sparking a fierce debate among investors over whether its substantial AI infrastructure investments will fuel significant cloud growth or exacerbate concerns about its rising debt and negative free cash flow. Conflicting reports regarding data center expansion plans with OpenAI and potential layoffs have further amplified market volatility and option activity.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. (CITR) is gaining attention as its CEO presents at the iAccess Alpha conference, driving community interest in the low-float stock's fire-retardant technology, which traders believe has significant potential in the growing market for fire prevention materials.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival (CCL) is a hot topic as escalating Middle East tensions and oil price volatility create headwinds for the travel sector, but the community is largely bullish, highlighting the company's record bookings, strong revenues, and reinstated dividend as reasons to buy on dips.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil (SCO) is trending as crude oil prices decline, driven by de-escalating geopolitical tensions and global supply considerations. Despite this, community frustration is widespread as the 2x inverse ETF's gains aren't proportional to oil's drop, prompting active discussion about its volatility decay and suitability for short-term bearish plays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Research Analysts Offer Predictions for PepGen Q1 Earnings

PepGen, Inc. (NASDAQ:PEPG - Free Report) - Analysts at HC Wainwright increased their Q1 2026 EPS estimates for PepGen in a research note issued to investors on Thursday, March 5th. HC Wainwright...

FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial

PepGen (PEPG) shifts focus to DM1 but faces a fresh FDA roadblock. Clinical data, analyst ratings, and technical support levels inside.read more...

PepGen (NASDAQ:PEPG) Posts Earnings Results, Beats Expectations By $0.11 EPS

PepGen (NASDAQ:PEPG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.38) by $0.11...

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...

PepGen Announces Regulatory Updates on FREEDOM2

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological diseases, today announced...

PepGen to Participate in the Leerink Global Healthcare Conference

Monashee Investment Management LLC Invests $1.39 Million in PepGen, Inc. $PEPG

Monashee Investment Management LLC acquired a new stake in PepGen, Inc. (NASDAQ:PEPG - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities...

PepGen (NASDAQ:PEPG) Now Covered by Analysts at Oppenheimer

Oppenheimer began coverage on PepGen in a research report on Wednesday. They issued an "outperform" rating and a $15.00 price objective for the company...

PepGen, Inc. (NASDAQ:PEPG) Receives Consensus Recommendation of "Moderate Buy" from Analysts

PepGen, Inc. (NASDAQ:PEPG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five analysts that are presently covering the firm, MarketBeat.com reports. One...

PepGen (PEPG) Expected to Announce Earnings on Monday

PepGen (NASDAQ:PEPG) will be releasing its Q4 2025 earnings before the market opens on Monday, February 23. (View Earnings Report at...

PepGen Inc

Leerink Global Healthcare Conference 2026

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

PEPG
PepGen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PEPG News

PEPGPepGen Inc